Close

BSTC Financial Facts

Total Cost and Expenses: 2.16M
Diluted net income (loss) per share: 0.42
See Full Income Statement

Deferred revenue: 1.22M
Cash and cash equivalents: 4.75M
See Full Balance Sheet

BioSpecifics Technologies Corp. (BSTC) Earnings

  |   Expand Research on BSTC
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -0.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.3% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/11/11 Q410 $0.02-$0.04 +$0.06$1.1M$1.38M N/A Details
5/8/14 Q114 $0.12$0.07 +$0.05$2.8M$2.46M N/A Details
8/9/16 Q216 $0.37$0.35 +$0.02$6.2M$6.25M N/A Details
8/11/14 Q214 $0.09$0.12 -$0.03$2.7M$2.91M N/A Details
8/9/12 Q212 $0.11$0.07 +$0.04$2.6M$2.5M N/A Details
11/10/14 Q314 $0.21$0.19 +$0.02$4M$4M N/A Details
3/14/16 Q416 $0.36N/A N/A $6.1M$4.6M N/A Details
5/11/15 Q414 $0.32N/A N/A $5.6M$2.3M N/A Details